Quick Answer
BIOREGENX, INC. reported Shares Outstanding of 956.99 million shares for fiscal year 2024.
BIOREGENX, INC. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2024 | 956.99M | +24.2% |
| 2023 | 770.83M | +185.8% |
| 2022 | 269.75M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 961.99M | +0.6% | +0.1% |
| June 30, 2025 | 961.16M | +0.5% | +0.1% |
| March 31, 2025 | 960.29M | — | +0.3% |
| December 31, 2024 | 956.99M | +24.2% | +0.0% |
| September 30, 2024 | 956.53M | +245.6% | +0.0% |
| June 30, 2024 | 956.53M | +245.6% | +24.1% |
| December 31, 2023 | 770.83M | +185.8% | +178.5% |
| September 30, 2023 | 276.75M | — | +0.0% |
- BIOREGENX, INC. showed an increase of +24.2% in Shares Outstanding compared to the prior fiscal year.
- Over the 2022–2024 period, BIOREGENX, INC.’s shares outstanding has grown by 254.8% (from 269.75 million shares to 956.99 million shares).
- The most recent figure is from BIOREGENX, INC.’s fiscal year 2024 report (Form 10-K), filed with the SEC on April 15, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: